Journals / Perinatal journal (Online) / 2022 / Cilt: 30 - Sayı: 2

Comparison of fetal cardiac structure in hypothyroid pregnant women receiving thyroid hormone replacement therapy and healthy controls

Pages
179–184
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thyroid replacement therapy in hypothyroid mothers might affect and treat fetal cardiac abnormalities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Thyroid hormone is required for normal fetal brain development, neuronal proliferation, migration and structural organization.
📊
Key Findings & Data:Methods: Singleton pregnant women whose ages were between 18–45 years and weeks of gestation were between 26–34 were included in the study.
💡
Conclusion & Impact:Thyroid replacement therapy in hypothyroid mothers might affect and treat fetal cardiac abnormalities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Thyroid hormone is required for normal fetal brain development, neuronal proliferation, migration and structural organization. We aimed to investigate fetal cardiac structure in fetuses of hypothyroid pregnant women receiving thyroid hormone replacement therapy and to compare it with normal pregnancies, including fetal outcome and delivery results. Methods: Singleton pregnant women whose ages were between 18–45 years and weeks of gestation were between 26–34 were included in the study. Their routine laboratory test reports, ultrasonographic measurements (fetal echo) and postnatal follow-up data were recorded. Patients were grouped according to the presence of diagnosis of hypothyroidism. The patients with hypothyroidism during pregnancy were included in Group 1 while healthy pregnancies with similar features were considered as controls and included in Group 2. All women with hypothyroidism were taking thyroid hormone replacement. All ultrasonographic and laboratory data measurements were collected from the system files and were compared between groups. Results: A total of 89 patients (41 hypothyroidism and 48 controls) were recruited to the study. Serum TSH levels of patients with hypothyroidism (Group 1) was significantly higher than the controls. In fetal cardiac examination, left ventricular (LV) and right ventricular (RV) wall thicknesses, and interventricular septum thicknesses at the end of systole and diastole were not statistically significant in both groups. Apgar scores, fetal gender and mean fetal birth weight were all similar between the groups. Conclusion: There is no myocardial structural difference in fetuses of pregnant women who were diagnosed with hypothyroidism and received thyroid hormone replacement therapy compared to healthy controls. Thyroid replacement therapy in hypothyroid mothers might affect and treat fetal cardiac abnormalities.

🔖

Cite This Article

UYSAL, G., MİHMANLI, V., ŞİRİNOĞLU, H. A., ATAKIR, K., GENÇ, S. (2022). Comparison of fetal cardiac structure in hypothyroid pregnant women receiving thyroid hormone replacement therapy and healthy controls. Perinatal journal (Online), Cilt: 30 - Sayı: 2, 179–184. https://ajindex.com/articles/588292

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Van den Boogaard E, Vissenberg R, Land JA, van Wely M, Van der Post J, Goddijn M, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 2011
  2. 605–19. [PubMed] [CrossRef] 2. Correction to: Thyroid 2017
  3. 315–89. DOI: 10.1089/ thy.2016.0457. Thyroid 2017
  4. [PubMed] [CrossRef] 3. Zhang Y, Wang H, Pan X, Teng W, Shan Z. Patients with subclinical hypothyroidism before 20 weeks of pregnancy have a higher risk of miscarriage: a systematic review and meta-analysis. PLoS One 2017
  5. e0175708. [PubMed] [CrossRef] 4. Lee SY, Cabral HJ, Aschengrau A, E Pearce E. Associations between maternal thyroid function in pregnancy and obstetric and perinatal outcomes. J Clin Endocrinol Metab 2020
  6. e2015–e2023. [PubMed] [CrossRef] 5. Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, Visser E, Visser W, de Muinck Keizer-Schrama S, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab 2013
  7. 4382–90. [PubMed] [CrossRef] 6. Wilson KL, Casey BM, McIntire DD, Halvorson LM, Cunningham FG. Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol 2012
  8. 315–20. [PubMed] [CrossRef] 7. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008
  9. 85–92. [PubMed] [CrossRef] 8. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab 2011
  10. E920–4. [PubMed] [CrossRef] 9. Ghassabian A, El Marroun H, Peeters RP, Jaddoe VW, Hofman A, Verhulst FC, et al. Downstream effects of maternal hypothyroxinemia in early pregnancy: nonverbal IQ and brain morphology in school-age children. J Clin Endocrinol Metab 2014
  11. 2383–90. [PubMed] [CrossRef] 10. Glinoer D. Management of hypo- and hyperthyroidism during pregnancy. Growth Horm IGF Res 2003
  12. 13 Suppl A:S45–54. [PubMed] [CrossRef] 11. Gencer B, Moutzouri E, Blum MR, Feller M, Collet TH, Delgiovane C, et al. The impact of levothyroxine on cardiac function in older adults with mild subclinical hypothyroidism: a randomized clinical trial. Am J Med 2020
  13. 848–56.e5. [PubMed] [CrossRef] 12. Udovcic M, Pena RH, Patham B, Tabatabai L, Kansara A. Hypothyroi